LABOCANNA S.A. ZY-10 (9Y2) - Total Liabilities
Based on the latest financial reports, LABOCANNA S.A. ZY-10 (9Y2) has total liabilities worth €7.71 Million EUR (≈ $9.01 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 9Y2 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
LABOCANNA S.A. ZY-10 - Total Liabilities Trend (2022–2025)
This chart illustrates how LABOCANNA S.A. ZY-10's total liabilities have evolved over time, based on quarterly financial data. See LABOCANNA S.A. ZY-10 (9Y2) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
LABOCANNA S.A. ZY-10 Competitors by Total Liabilities
The table below lists competitors of LABOCANNA S.A. ZY-10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Intercede Group
LSE:IGP
|
UK | GBX11.09 Million |
|
Ondine Biomedical Inc
LSE:OBI
|
UK | GBX10.91 Million |
|
Oriental Rise Holdings Limited Ordinary Shares
NASDAQ:ORIS
|
USA | $2.78 Million |
|
Yolo SA
WAR:YOL
|
Poland | zł27.26 Million |
|
Biomotion Sciences Ordinary Shares
NASDAQ:SLXN
|
USA | $4.31 Million |
|
Eco Animal Health Group Plc
LSE:EAH
|
UK | GBX21.57 Million |
|
Maven Income And Growth Vct Plc
LSE:MIG1
|
UK | GBX449.00K |
|
Jade Leader Corp
V:JADE
|
Canada | CA$456.03K |
Liability Composition Analysis (2022–2025)
This chart breaks down LABOCANNA S.A. ZY-10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see LABOCANNA S.A. ZY-10 market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.83 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LABOCANNA S.A. ZY-10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LABOCANNA S.A. ZY-10 (2022–2025)
The table below shows the annual total liabilities of LABOCANNA S.A. ZY-10 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €7.71 Million ≈ $9.01 Million |
+357.43% |
| 2024-12-31 | €1.68 Million ≈ $1.97 Million |
+207.44% |
| 2023-12-31 | €548.01K ≈ $640.69K |
-53.81% |
| 2022-12-31 | €1.19 Million ≈ $1.39 Million |
-- |
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its name to Labocanna S.A. in January 2021. Labocanna S.A. was incorporat… Read more